Malignant syphilis in HIV negative patient treated with ibrutinib
Rev Esp Quimioter. 2023 Dec 29:aroza29sep2023. doi: 10.37201/req/027.2023. Online ahead of print.NO ABSTRACTPMID:37772340 | DOI:10.37201/req/027.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 29, 2023 Category: Drugs & Pharmacology Authors: M Aroza-Espinar A Merl án-Hermida L Su árez-Hormiga J L P érez-Arellano Source Type: research
Wound infection caused by Pasteurella canis and Neisseria animaloris after a dog bite
Rev Esp Quimioter. 2023 Dec 29:fernandez29sep2023. doi: 10.37201/req/035.2023. Online ahead of print.NO ABSTRACTPMID:37772341 | DOI:10.37201/req/035.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 29, 2023 Category: Drugs & Pharmacology Authors: D Fern ández Vecilla C Aspichueta Vivanco E Ugalde Z árraga J L D íaz de Tuesta Del Arco Source Type: research
Malignant syphilis in HIV negative patient treated with ibrutinib
Rev Esp Quimioter. 2023 Dec 29:aroza29sep2023. doi: 10.37201/req/027.2023. Online ahead of print.NO ABSTRACTPMID:37772340 | DOI:10.37201/req/027.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 29, 2023 Category: Drugs & Pharmacology Authors: M Aroza-Espinar A Merl án-Hermida L Su árez-Hormiga J L P érez-Arellano Source Type: research
Wound infection caused by Pasteurella canis and Neisseria animaloris after a dog bite
Rev Esp Quimioter. 2023 Dec 29:fernandez29sep2023. doi: 10.37201/req/035.2023. Online ahead of print.NO ABSTRACTPMID:37772341 | DOI:10.37201/req/035.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 29, 2023 Category: Drugs & Pharmacology Authors: D Fern ández Vecilla C Aspichueta Vivanco E Ugalde Z árraga J L D íaz de Tuesta Del Arco Source Type: research
Identification of curved Gram-negative rods by MALDI-TOF mass spectrometer in a patient with Fournier ́s gangrene. A bacteremia caused by Desulfovibrio desulfuricans and Escherichia coli
Rev Esp Quimioter. 2023 Dec 28:fernandez28sep2023. doi: 10.37201/req/026.2022. Online ahead of print.NO ABSTRACTPMID:37767548 | DOI:10.37201/req/026.2022 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 28, 2023 Category: Drugs & Pharmacology Authors: D Fern ández Vecilla M P Roche Matheus F E Calvo Muro G Iglesias Hidalgo J L D íaz de Tuesta Del Arco Source Type: research
Identification of curved Gram-negative rods by MALDI-TOF mass spectrometer in a patient with Fournier ́s gangrene. A bacteremia caused by Desulfovibrio desulfuricans and Escherichia coli
Rev Esp Quimioter. 2023 Dec 28:fernandez28sep2023. doi: 10.37201/req/026.2022. Online ahead of print.NO ABSTRACTPMID:37767548 | DOI:10.37201/req/026.2022 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 28, 2023 Category: Drugs & Pharmacology Authors: D Fern ández Vecilla M P Roche Matheus F E Calvo Muro G Iglesias Hidalgo J L D íaz de Tuesta Del Arco Source Type: research
Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy
CONCLUSIONS: Bacterial coinfection is common in COVID patients admitted to the ICU and increases the risk of death. It is not possible to identify with certainty, at the time of admission, which patients do not benefit from antibiotic treatment.PMID:37743661 | DOI:10.37201/req/060.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 25, 2023 Category: Drugs & Pharmacology Authors: P Vidal-Cort és J Nieto Del Olmo A I Tiz ón Varela E Seoane Fern ández F Eiras Abalde J Blanco Chapela L Larra ñaga Sigwald D E Su árez Fernández P Fern ández Ugidos L Del R ío Carbajo Source Type: research
Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy
CONCLUSIONS: Bacterial coinfection is common in COVID patients admitted to the ICU and increases the risk of death. It is not possible to identify with certainty, at the time of admission, which patients do not benefit from antibiotic treatment.PMID:37743661 | DOI:10.37201/req/060.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 25, 2023 Category: Drugs & Pharmacology Authors: P Vidal-Cort és J Nieto Del Olmo A I Tiz ón Varela E Seoane Fern ández F Eiras Abalde J Blanco Chapela L Larra ñaga Sigwald D E Su árez Fernández P Fern ández Ugidos L Del R ío Carbajo Source Type: research
Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy
CONCLUSIONS: Bacterial coinfection is common in COVID patients admitted to the ICU and increases the risk of death. It is not possible to identify with certainty, at the time of admission, which patients do not benefit from antibiotic treatment.PMID:37743661 | DOI:10.37201/req/060.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 25, 2023 Category: Drugs & Pharmacology Authors: P Vidal-Cort és J Nieto Del Olmo A I Tiz ón Varela E Seoane Fern ández F Eiras Abalde J Blanco Chapela L Larra ñaga Sigwald D E Su árez Fernández P Fern ández Ugidos L Del R ío Carbajo Source Type: research
Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research
Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research
Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research
Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project
CONCLUSIONS: The pharmaceutical intervention based onarmaceutical intervention based on the CMO methodology significantly decreased the prevalence of the PIMDINAC concept and increased the number of patients who achieved the objectives, optimising their pharmacotherapy.PMID:37724451 | DOI:10.37201/req/021.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 19, 2023 Category: Drugs & Pharmacology Authors: E S ánchez-Yáñez M J Huertas-Fern ández M A Robustillo-Cortes R Ramos-Guerrero S Fern ández-Espínola R Diaz-Acedo V Montero-Martin R Morillo-Verdugo Source Type: research
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project
CONCLUSIONS: The pharmaceutical intervention based onarmaceutical intervention based on the CMO methodology significantly decreased the prevalence of the PIMDINAC concept and increased the number of patients who achieved the objectives, optimising their pharmacotherapy.PMID:37724451 | DOI:10.37201/req/021.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 19, 2023 Category: Drugs & Pharmacology Authors: E S ánchez-Yáñez M J Huertas-Fern ández M A Robustillo-Cortes R Ramos-Guerrero S Fern ández-Espínola R Diaz-Acedo V Montero-Martin R Morillo-Verdugo Source Type: research
